Fig. 3.
The correlation between decay-accelerating factor (DAF) levels (a) and CD59 levels (b) and C3 deposition after in vitro complement activation on erythrocytes from RA patients.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.